Wird geladen...
Cholinesterase inhibitor use does not significantly influence the ability of (123)I‐FP‐CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies
BACKGROUND: (123)I‐labelled 2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane ((123)I‐FP‐CIT) imaging is a diagnostic tool to help differentiate dementia with Lewy bodies (DLB) from Alzheimer's disease (AD). However, in animals, cholinesterase inhibitors (ChEi) have been reported...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Group
2007
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2117542/ https://ncbi.nlm.nih.gov/pubmed/17299017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.2006.111666 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|